DURECT CEO and leadership

James E. Brown, D.V.M. co-founded DURECT in February 1998 and has served as President, Chief Executive Officer and a Director since June 1998. He previously worked at ALZA Corporation as Vice President of Biopharmaceutical and Implant Research and Development from June 1995 to June 1998. Prior to that, Dr. Brown held various positions at Syntex Corporation, a pharmaceutical company, including Director of Business Development from May 1994 to May 1995, Director of Joint Ventures for Discovery Research from April 1992 to May 1995, and held a number of positions including Program Director for Syntex Research and Development from October 1985 to March 1992. Dr. Brown holds a B.A. from San Jose State University and a D.V.M. (Doctor of Veterinary Medicine) from the University of California, Davis where he also conducted post-graduate work in pharmacology and toxicology.

Felix Theeuwes is a Chairman and Chief Scientific Officer at DURECT CORP. He has worked as Chief Scientific Officer, President ALZA Research at ALZA Corporation. Felix attended Stanford Graduate School of Business between 1993 and 1993.

Steven Helmer is a VP/Chief Patent Counsel at DURECT CORP and is based in San Francisco Bay Area. He has worked as Patent Counsel at Nektar Therapeutics, Associate at Finnegan Henderson Farabow Garrett & Dunner LLP, and IP Counsel at LIFE TECHNOLOGIES CORP. Steven studied at University of Minnesota Law School between 1991 and 1994, Sigma Gamma Tau National Honor Society in Aerospace Engineering, and JOHNS HOPKINS UNIVERSITY between 1998 and 2001.

Norman L Sussman is a Board Member at Stem Cell Innovations Inc and Chief Medical Officer at DURECT CORP and is based in Cupertino, California. He has worked as VP/Founder at Hepatix, Vice President of Medical Affairs at Hepatix, and Founder and Executive Vice President at Amphioxus Cell Technologies Inc. Norman works or has worked as FELLOW at American Association of the Study of Liver Disease. He attended University of the Witwatersrand between 1971 and 1976.

James E. Brown, D.V.M. co-founded DURECT in February 1998 and has served as President, Chief Executive Officer and a Director since June 1998. He previously worked at ALZA Corporation as Vice President of Biopharmaceutical and Implant Research and Development from June 1995 to June 1998. Prior to that, Dr. Brown held various positions at Syntex Corporation, a pharmaceutical company, including Director of Business Development from May 1994 to May 1995, Director of Joint Ventures for Discovery Research from April 1992 to May 1995, and held a number of positions including Program Director for Syntex Research and Development from October 1985 to March 1992. Dr. Brown holds a B.A. from San Jose State University and a D.V.M. (Doctor of Veterinary Medicine) from the University of California, Davis where he also conducted post-graduate work in pharmacology and toxicology.

Felix Theeuwes is a Chairman and Chief Scientific Officer at DURECT CORP. He has worked as Chief Scientific Officer, President ALZA Research at ALZA Corporation. Felix attended Stanford Graduate School of Business between 1993 and 1993.

James E. Brown, D.V.M. co-founded DURECT in February 1998 and has served as President, Chief Executive Officer and a Director since June 1998. He previously worked at ALZA Corporation as Vice President of Biopharmaceutical and Implant Research and Development from June 1995 to June 1998. Prior to that, Dr. Brown held various positions at Syntex Corporation, a pharmaceutical company, including Director of Business Development from May 1994 to May 1995, Director of Joint Ventures for Discovery Research from April 1992 to May 1995, and held a number of positions including Program Director for Syntex Research and Development from October 1985 to March 1992. Dr. Brown holds a B.A. from San Jose State University and a D.V.M. (Doctor of Veterinary Medicine) from the University of California, Davis where he also conducted post-graduate work in pharmacology and toxicology.

Felix Theeuwes is a Chairman and Chief Scientific Officer at DURECT CORP. He has worked as Chief Scientific Officer, President ALZA Research at ALZA Corporation. Felix attended Stanford Graduate School of Business between 1993 and 1993.